A carregar...
Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course
Denosumab is a receptor activator of nuclear factor kappa-B (RANK) ligand inhibitor used in the treatment of osteoporosis. Blockade of RANK ligand prevents osteoclastic resorption of bone, but in doing so impairs the parathyroid hormone (PTH)-driven maintenance of serum calcium. A subsequent elevati...
Na minha lista:
| Publicado no: | Case Rep Nephrol Dial |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6514500/ https://ncbi.nlm.nih.gov/pubmed/31192226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000499824 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|